Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 63


Engineering Factor Xa Inhibitor with Multiple Platelet-Binding Sites Facilitates its Platelet Targeting.

Zhu Y, Li R, Lin Y, Shui M, Liu X, Chen H, Wang Y.

Sci Rep. 2016 Jul 19;6:29895. doi: 10.1038/srep29895.


Energetic Mechanism of Cytochrome c-Cytochrome c Oxidase Electron Transfer Complex Formation under Turnover Conditions Revealed by Mutational Effects and Docking Simulation.

Sato W, Hitaoka S, Inoue K, Imai M, Saio T, Uchida T, Shinzawa-Itoh K, Yoshikawa S, Yoshizawa K, Ishimori K.

J Biol Chem. 2016 Jul 15;291(29):15320-31. doi: 10.1074/jbc.M115.708065. Epub 2016 May 13.


Identification of an activation site in Bak and mitochondrial Bax triggered by antibodies.

Iyer S, Anwari K, Alsop AE, Yuen WS, Huang DC, Carroll J, Smith NA, Smith BJ, Dewson G, Kluck RM.

Nat Commun. 2016 May 24;7:11734. doi: 10.1038/ncomms11734.


Evaluation of the coarse-grained OPEP force field for protein-protein docking.

Kynast P, Derreumaux P, Strodel B.

BMC Biophys. 2016 Apr 21;9:4. doi: 10.1186/s13628-016-0029-y. eCollection 2016.


TOPK promotes lung cancer resistance to EGFR tyrosine kinase inhibitors by phosphorylating and activating c-Jun.

Li Y, Yang Z, Li W, Xu S, Wang T, Wang T, Niu M, Zhang S, Jia L, Li S.

Oncotarget. 2016 Feb 9;7(6):6748-64. doi: 10.18632/oncotarget.6826.


Molecular basis for the antagonistic activity of an anti-CXCR4 antibody.

Peng L, Damschroder MM, Cook KE, Wu H, Dall'Acqua WF.

MAbs. 2016;8(1):163-75. doi: 10.1080/19420862.2015.1113359.


Epigenetic factor EPC1 is a master regulator of DNA damage response by interacting with E2F1 to silence death and activate metastasis-related gene signatures.

Wang Y, Alla V, Goody D, Gupta SK, Spitschak A, Wolkenhauer O, Pützer BM, Engelmann D.

Nucleic Acids Res. 2016 Jan 8;44(1):117-33. doi: 10.1093/nar/gkv885. Epub 2015 Sep 8.


Ctr9, a Protein in the Transcription Complex Paf1, Regulates Dopamine Transporter Activity at the Plasma Membrane.

De Gois S, Slama P, Pietrancosta N, Erdozain AM, Louis F, Bouvrais-Veret C, Daviet L, Giros B.

J Biol Chem. 2015 Jul 17;290(29):17848-62. doi: 10.1074/jbc.M115.646315. Epub 2015 Jun 5.


Modeling of the OX1R-orexin-A complex suggests two alternative binding modes.

Karhu L, Turku A, Xhaard H.

BMC Struct Biol. 2015 May 9;15:9. doi: 10.1186/s12900-015-0036-2.


Molecular basis for antagonistic activity of anifrolumab, an anti-interferon-α receptor 1 antibody.

Peng L, Oganesyan V, Wu H, Dall'Acqua WF, Damschroder MM.

MAbs. 2015;7(2):428-39. doi: 10.1080/19420862.2015.1007810.


Scoring docking conformations using predicted protein interfaces.

Esmaielbeiki R, Nebel JC.

BMC Bioinformatics. 2014 Jun 6;15:171. doi: 10.1186/1471-2105-15-171.


In silico analysis reveals sequential interactions and protein conformational changes during the binding of chemokine CXCL-8 to its receptor CXCR1.

Liou JW, Chang FT, Chung Y, Chen WY, Fischer WB, Hsu HJ.

PLoS One. 2014 Apr 4;9(4):e94178. doi: 10.1371/journal.pone.0094178. eCollection 2014.


3D modeling and characterization of the human CD115 monoclonal antibody H27K15 epitope and design of a chimeric CD115 target.

Grellier B, Le Pogam F, Vitorino M, Starck JP, Geist M, Duong V, Haegel H, Menguy T, Bonnefoy JY, Marchand JB, Ancian P.

MAbs. 2014 Mar-Apr;6(2):533-46. doi: 10.4161/mabs.27736. Epub 2014 Jan 6.


Elucidating the interacting domains of chandipura virus nucleocapsid protein.

Kumar K, Rajasekharan S, Gulati S, Rana J, Gabrani R, Jain CK, Gupta A, Chaudhary VK, Gupta S.

Adv Virol. 2013;2013:594319. doi: 10.1155/2013/594319. Epub 2013 Oct 28.


3D Molecular Modelling Study of the H7N9 RNA-Dependent RNA Polymerase as an Emerging Pharmacological Target.

Vlachakis D, Karozou A, Kossida S.

Influenza Res Treat. 2013;2013:645348. doi: 10.1155/2013/645348. Epub 2013 Sep 25.


p34 is a novel regulator of the oncogenic behavior of NEDD4-1 and PTEN.

Hong SW, Moon JH, Kim JS, Shin JS, Jung KA, Lee WK, Jeong SY, Hwang JJ, Lee SJ, Suh YA, Kim I, Nam KY, Han S, Kim JE, Kim KP, Hong YS, Lee JL, Lee WJ, Choi EK, Lee JS, Jin DH, Kim TW.

Cell Death Differ. 2014 Jan;21(1):146-60. doi: 10.1038/cdd.2013.141. Epub 2013 Oct 18.


How to use not-always-reliable binding site information in protein-protein docking prediction.

Li L, Huang Y, Xiao Y.

PLoS One. 2013 Oct 4;8(10):e75936. doi: 10.1371/journal.pone.0075936. eCollection 2013.


Insight into the intermolecular recognition mechanism between Keap1 and IKKβ combining homology modelling, protein-protein docking, molecular dynamics simulations and virtual alanine mutation.

Jiang ZY, Chu HX, Xi MY, Yang TT, Jia JM, Huang JJ, Guo XK, Zhang XJ, You QD, Sun HP.

PLoS One. 2013 Sep 16;8(9):e75076. doi: 10.1371/journal.pone.0075076. eCollection 2013.

Items per page

Supplemental Content

Write to the Help Desk